Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Injectable platelet-rich fibrin therapy improved hair and scalp conditions in women with excessive hair loss.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Combining PRP with hydroquinone is more effective for treating melasma than using hydroquinone alone.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Isotretinoin can safely and effectively control acne with proper risk management and monitoring.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

No cure for female pattern hair loss, but various effective treatments exist.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Early treatment of PCOS is crucial for better health and quality of life.

Alternative treatments show promise for hair growth beyond traditional methods.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

EH-MSCs may help treat hair loss by reducing inflammation.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Some breast cancer chemotherapy can cause permanent hair loss.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.